WELL, WELL, WELL ... I just received a "SWEET

New Post Public Reply Private Reply Replies (6) Message Board
lajet
1,082
WELL, WELL, WELL ...

I just received a "SWEET Confirmation" from Foxxum themselves ... regarding the announced Foxxum - UltraFlix deal for "International distribution" of the UltraFlix 4K Ultra HD network.

I contacted Foxxum via email ... And after 5 days time, I received an email response DIRECTLY from Foxxum ... a person with the title of "Senior Associate, Customer Delivery" ...

Unfortunately, the email response I received from Foxxum contained the below NDA notification ... so I am unable to share the actual content of their communication ...

Ummm, Well ... I think I'll share the first 3 words of the email response ...

"Foxxum is indeed ..." ...
Quote:
Foxxum GmbH
Wall 55 · 24103 Kiel · Germany
Phone +49 431 260 4105 0
Mail vvvvvvvv@foxxum.com
Skype foxxum_vvvvvvvv
Follow us on twitter: twitter.com/foxxum

Foxxum GmbH · HRB 13103 Kiel · UStId: DE278364654 · Chief Executive Officer: Ronny Lutzi

This e-mail may contain confidential and/or privileged information. If you are not the intended recipient (or have received this e-mail in error) please notify the sender immediately and destroy this e-mail. Any unauthorized copying, disclosure or distribution of the material in this e-mail is strictly forbidden. All information in this e-mail are protected by NDA.

Please don't print this e-mail if you don't need to.
So my reaction to the DIRECT response that I received from Foxxum ...

... ... ... ... ... ... ... ... ... ... Woo Hoo !!!

I simply sent an email message through the Foxxum website using their Contact Form ...
https://foxxum.com/contact/

... Feel free to inquire for yourself !! ... hehehehe ...

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Frontera Energy Set to Release Quarterly Financial Results Soon

Updated Category News Views 253

Frontera Energy Announces First Quarter Financial Results Frontera Energy Corporation (TSX: FEC) has exciting news for its shareholders and interested investors. The Company is set to unveil its financial and operational results for the first quarter, wrapping up on March 31, 2025. This significant announcement will occur after the market closes on a forthcoming Thursday...

Continue Reading
The Rising Value of Contrast Media Injectors in Healthcare

Updated Category News Views 133

Exploring the Global Market for Contrast Media Injectors The global market for contrast media injectors is on the verge of substantial growth, with projections indicating it will reach $2.1 billion in the coming years. This anticipated growth, at a compound annual growth rate (CAGR) of 7.8% from 2025 through 2033, is primarily driven by ongoing advances in technology and...

Continue Reading
Beth Wozniak Sells nVent Electric Shares Worth $884K

Updated Category News Views 158

Beth Wozniak's Recent Stock Sale at nVent Electric Beth Wozniak, Chair & CEO of nVent Electric (NYSE:NVT), executed a significant insider sale recently, as revealed in a new SEC filing. This transaction involved the offloading of 7,597 shares, with a total value of approximately $884,822. Such movements in stock ownership often pique the interest of investors, prompting...

Continue Reading
Electoral Impact of Rising Home Prices on Kamala Harris' Campaign

Updated Category News Views 211

The Impact of Home Prices on the Upcoming Election As we approach the presidential election, the role that home prices play in shaping voter sentiments is becoming increasingly evident. Recent research has shown that fluctuations in the housing market can significantly affect how voters make their choices, particularly in crucial battleground states. Current Trends in...

Continue Reading
Iambic Therapeutics Welcomes Michael Secora as CFO and CDO

Updated Category News Views 134

Iambic Therapeutics Welcomes Michael Secora as CFO and CDO Iambic Therapeutics has announced an important leadership change, appointing Michael Secora, Ph.D., as its Chief Corporate Development Officer and Chief Financial Officer. This decision comes as Iambic continues its commitment to pioneering novel medicines through its innovative AI-driven drug discovery platform....

Continue Reading